A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

The ACG has revised its guidance for gastric premalignant conditions, such as atrophic gastritis, gastric intestinal ...

The herb rosemary has long been linked with memory: "There's rosemary, that's for remembrance," says Ophelia in Shakespeare's ...

PanCAN strongly recommends clinical trials at diagnosis and during every treatment decision. Clinical trials are research studies that investigate new treatments or new combinations of treatments.

The Food and Drug Administration (FDA) has approved Tevimbra® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the ...

Background: Neoadjuvant therapy is widely used for esophageal cancer (EC), but optimal treatment regimens and predictive factors for outcomes remain unclear. This study retrospectively analyzed data ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that ...

The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...

BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1 ...

Your doctor and nurse will talk to you about the chemotherapy that is best for your situation. They will explain how long your treatment is likely to take. Some chemotherapy treatments for head and ...

Natural remedies may work as an additional treatment to help manage symptoms. Hyperthyroidism occurs when the body produces too much thyroid hormone. It affects the thyroid gland, which is located ...